Early research (Phase 1)Not Yet RecruitingNCT07830758
What this trial is testing
Resmetirom in Patients With MASH and HFpEF
Who this might be right for
MASH - Metabolic Dysfunction-Associated SteatohepatitisHeart Failure With Preserved Ejection Fraction (HFPEF)
Madrigal Pharmaceuticals, Inc. 90